Nyxoah SA is a medical technology company focused on developing and commercializing solutions for obstructive sleep apnea, a common sleep-disordered breathing condition. Nyxoah’s lead product is the Genio system, a patient-centered hypoglossal neurostimulation therapy designed to help treat moderate to severe obstructive sleep apnea. The company operates in the healthcare equipment and neuromodulation space, serving a medical market that relies on minimally invasive technologies to address chronic respiratory and sleep-related disorders. Nyxoah SA is headquartered in Mont-Saint-Guibert, Belgium, and its current business centers on bringing sleep apnea treatment alternatives to clinical practice through its proprietary Genio platform.
WebsiteRue Edouard Belin 12
Mont-Saint-Guibert, MI, 1435
Belgium
Nyxoah (NYXH) appointed Liam Kelly as chief executive officer, starting Oct. 1, succeeding Olivier T
Nyxoah SA (NASDAQ:NYXH) announced the first patient implantation in BREATHE on September 7. The prospective, single-arm U.S. post-approval study will evaluate Genio hypoglossal-nerve stimulation in adults aged 22 or older with moderate to severe obstructive sleep apnea for whom standard-care treatments have failed, cannot be tolerated, or are unsuitable. Plans call for up to 229 […]
NYXH initiates its U.S. BREATHE study with the first Genio implant, advancing long-term clinical evidence following FDA approval.
Investors talking about NYXH also mention
What share of all stock conversation is about NYXH?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% +0 | 0% 0 |
Of the messages about NYXH that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% | 100% | 87.5% -12.5 | 92.19% +8.12 | ||
| Bearish | 0% | 0% | 12.5% new | 7.81% -8.12 |
Of the messages about NYXH that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 100% | 100% | 50% | 92.43% | ||
| Technical Analysis | 0% | 0% | 50% | 2.96% | ||
| Analysts | 0% | 0% | 0% | 2.3% | ||
| Controversies | 0% | 0% | 0% | 1.64% | ||
| Earnings | 0% | 0% | 0% | 0.66% | ||
| Macro | 0% | 0% | 0% | 0% |
Of the messages about NYXH, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 50% | 33.33% | 13.16% | 17.24% | ||
| Newcomers | 50% | 66.67% | 86.84% | 82.76% |